Systemic therapy for advanced adrenal cancer.

Abstract

The systemic management of advanced adrenal cancer remains a major therapeutic dilemma as it is both highly resistant to systemic agents and very rare epithelial neoplasm making clinical investigation a significant challenge. The role of mitotane, systemic chemotherapy and novel targeted agents are reviewed.

• Authors: Robert Dreicer
• Journal: Journal of surgical oncology (J Surg Oncol) Vol. 106 Issue 5 Pg. 643-6 (Oct 01 2012) ISSN: 1096-9098 [Electronic] United States
• PMID: 22488742 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2012 Wiley Periodicals, Inc.

Topics

• Adrenal Gland Neoplasms (therapy)
• Animals
• Humans